Triple-negative breast cancer (TNBC) is a breast cancer subtype with negative expressions of estrogen receptor (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.